The Austrian Supreme Court in its Edwards Lifesciences/JenaValve decision dated 26 March 2025 (16 Ok 2/25t) examines under which circumstances the acquired target undertaking/business ‘is active’ in Austria ‘to a significant extent’. Only if this requirement...
Read more